Valiant Organics
287.66
+21.02(+7.88%)
Market Cap₹794.35 Cr
PE Ratio34.46
IndustryChemicals
Company Performance:
1D+7.88%
1M+38.49%
6M-4.54%
1Y-18.99%
5Y-79.75%
View Company Insightsright
More news about Valiant Organics
26Sept 25
Valiant Organics Shareholders Approve Key Appointments and Secretarial Auditor at 20th AGM
Valiant Organics Limited held its 20th AGM on September 26, approving several important resolutions. Shareholders re-appointed Shri Mahek M. Chheda as Executive Director and Shri Kiritkumar H. Desai as Non-Executive Director. M/s Mehta & Mehta was appointed as the new Secretarial Auditor for five years. The company reported an operating revenue of 719.00 crore for FY 2024-25 with an EBITDA margin of 7.47%. Other approvals included remuneration for the Managing Director and Cost Auditor, and material related party transactions.
 no imag found
20Aug 25
Valiant Organics Reports Strong Q1 Recovery with 58% EBITDA Growth
Valiant Organics, a specialty chemicals manufacturer, reported impressive Q1 results. Revenue from operations grew 21.7% year-on-year to INR 2,044.00 million. Operating EBITDA surged 58% to INR 248.00 million, with EBITDA margins expanding by 278 basis points to 12.13%. The company turned profitable with a PAT of INR 82.00 million, compared to a loss in the previous year. Hydrogenation segment was the largest revenue contributor at 53%. The company maintains a strong financial position with a net worth of INR 5,698.00 million and a net debt to equity ratio of 0.33.
 no imag found
15Aug 25
Valiant Organics Reports 22% Revenue Growth and Significant Profit Surge in Q1
Valiant Organics posted consolidated revenue of Rs 205.48 crore, up 22% year-over-year. Net profit surged to Rs 8.20 crore from Rs 0.62 crore. EBITDA rose 53% to Rs 19.75 crore, with margin improving to 9.60%. EPS increased to Rs 2.93 from Rs 0.23. Management projects 15-20% revenue growth for the full year with EBITDA margins of 10-12%. The company plans capital expenditure of Rs 100-120 crore for capacity expansion and new product development.
 no imag found
19Jun 25
Valiant Organics to Explore Fundraising Options in Upcoming Board Meeting
Valiant Organics Limited, a key player in the chemical industry, has announced a board meeting scheduled for June 25 to discuss and consider various fundraising options. This move could potentially impact the company's future growth strategies and financial structure. The specific details of the fundraising options have not been disclosed, but the decision could influence the company's stock performance and long-term prospects.
 no imag found
12Jun 25
Valiant Organics Withdraws ₹500 Million Rights Issue Citing Regulatory Changes
Valiant Organics Limited has withdrawn its proposed ₹500 million rights issue, citing unspecified regulatory changes as the reason. The decision impacts the company's capital raising strategy and maintains its current capital structure. The move reflects the company's cautious approach to compliance with evolving financial regulations in India. Shareholders and investors are advised to watch for alternative capital raising plans or strategic moves from the company.
 no imag found
Valiant Organics
287.66
+21.02
(+7.88%)
1 Year Returns:-18.99%
Industry Peers
Pidilite Industries
1,331.00
(+0.11%)
SRF
2,504.00
(+0.14%)
Gujarat Fluorochemicals
3,376.70
(-0.07%)
Deepak Nitrite
1,533.70
(+0.73%)
Atul
6,598.50
(+0.75%)
BASF
3,680.70
(+0.29%)
Aarti Industries
437.90
(+1.44%)
Aether Industries
1,187.40
(+0.79%)